ASTH Stock Overview
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Astrana Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$42.91 |
| 52 Week High | US$63.20 |
| 52 Week Low | US$32.00 |
| Beta | 1.24 |
| 11 Month Change | -23.69% |
| 3 Month Change | -7.88% |
| 1 Year Change | 25.76% |
| 33 Year Change | -64.08% |
| 5 Year Change | 165.37% |
| Change since IPO | 295.85% |
Recent News & Updates
Recent updates
Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results
Nov 10
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce
Oct 04Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?
Sep 26Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
Sep 12Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Shareholder Returns
| ASTH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -23.4% | 7.8% | 5.7% |
| 1Y | 25.8% | 8.3% | 36.9% |
Return vs Industry: ASTH exceeded the US Healthcare industry which returned 8.3% over the past year.
Return vs Market: ASTH underperformed the US Market which returned 36.9% over the past year.
Price Volatility
| ASTH volatility | |
|---|---|
| ASTH Average Weekly Movement | 7.6% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ASTH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ASTH's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 1,800 | Brandon Sim | www.astranahealth.com |
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Astrana Health, Inc. Fundamentals Summary
| ASTH fundamental statistics | |
|---|---|
| Market cap | US$2.24b |
| Earnings (TTM) | US$62.46m |
| Revenue (TTM) | US$1.72b |
32.8x
P/E Ratio1.2x
P/S RatioIs ASTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASTH income statement (TTM) | |
|---|---|
| Revenue | US$1.72b |
| Cost of Revenue | US$1.46b |
| Gross Profit | US$259.89m |
| Other Expenses | US$197.43m |
| Earnings | US$62.46m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.31 |
| Gross Margin | 15.09% |
| Net Profit Margin | 3.63% |
| Debt/Equity Ratio | 86.4% |
How did ASTH perform over the long term?
See historical performance and comparison